| Original language | English |
|---|---|
| Qualification | Doctor of Pharmaceutical Sciences |
| Awarding Institution |
|
| Supervisors/Advisors |
|
| Award date | 28 Jun 2023 |
| Publication status | Unpublished - 28 Jun 2023 |
Engineering of triketone-insensitive human 4-hydroxyphenylpyruvate dioxygenase enzymes as a basis to develop a new gene therapy for hereditary tyrosinemia type 1
Research output: Thesis › PhD Thesis